tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

EXAI Stock Latest News

Exscientia Plc Faces Financial Challenges Amid Rising Costs
Company AnnouncementsExscientia Plc Faces Financial Challenges Amid Rising Costs
2d ago
6K
EXAI
Exscientia Plc Enhances Board Collaboration with Recursion
PremiumCompany Announcements
Exscientia Plc Enhances Board Collaboration with Recursion
4d ago
6K
EXAI
Exscientia advances two additional discovery programs with Sanofi
PremiumThe Fly
Exscientia advances two additional discovery programs with Sanofi
25d ago
SNY
EXAI
Exscientia Set for Strategic Acquisition by Recursion
PremiumCompany Announcements
Exscientia Set for Strategic Acquisition by Recursion
1M ago
6K
EXAI
Exscientia Plc Backs Acquisition by Recursion Pharmaceuticals
PremiumCompany Announcements
Exscientia Plc Backs Acquisition by Recursion Pharmaceuticals
2M ago
6K
EXAI
Exscientia’s Strategic Merger and Pipeline Progress
PremiumCompany AnnouncementsExscientia’s Strategic Merger and Pipeline Progress
3M ago
6K
EXAI
Exscientia reports Q2 EPS (36c) vs. (37c) last year
Premium
The Fly
Exscientia reports Q2 EPS (36c) vs. (37c) last year
3M ago
EXAI
Small Cap Stocks: Recursion Pharmaceuticals (RXRX) Applying AI and Strategic Partnerships
Premium
Market News
Small Cap Stocks: Recursion Pharmaceuticals (RXRX) Applying AI and Strategic Partnerships
3M ago
MRK
SNY
Exscientia downgraded to Equal Weight from Overweight at Barclays
PremiumThe Fly
Exscientia downgraded to Equal Weight from Overweight at Barclays
3M ago
EXAI
Is EXAI a Buy, Before Earnings?
PremiumPre-Earnings
Is EXAI a Buy, Before Earnings?
3M ago
EXAI
Exscientia Agrees to Acquisition by Recursion Pharmaceuticals
PremiumCompany Announcements
Exscientia Agrees to Acquisition by Recursion Pharmaceuticals
3M ago
6K
EXAI
Exscientia downgraded to Hold from Buy at TD Cowen
PremiumThe Fly
Exscientia downgraded to Hold from Buy at TD Cowen
3M ago
EXAI
Recursion Pharmaceuticals to combine with Exscientia in all-stock deal
PremiumThe FlyRecursion Pharmaceuticals to combine with Exscientia in all-stock deal
3M ago
EXAI
RXRX
Exscientia price target lowered to $9 from $10 at Barclays
Premium
The Fly
Exscientia price target lowered to $9 from $10 at Barclays
3M ago
EXAI
Exscientia Secures Full Rights to Novel Cancer Drug
Premium
Company Announcements
Exscientia Secures Full Rights to Novel Cancer Drug
4M ago
6K
EXAI
Exscientia pays GT Apeiron $10M upfont cash+ equity for ‘full control’ of 617
PremiumThe Fly
Exscientia pays GT Apeiron $10M upfont cash+ equity for ‘full control’ of 617
4M ago
EXAI
Exscientia launches AWS AI-powered platform to advance drug discovery
PremiumThe Fly
Exscientia launches AWS AI-powered platform to advance drug discovery
4M ago
EXAI
Exscientia initiated with a Buy at TD Cowen
PremiumThe Fly
Exscientia initiated with a Buy at TD Cowen
4M ago
EXAI
Class Action Lawsuit against Exscientia PLC (NASDAQ:EXAI)
PremiumMarket News
Class Action Lawsuit against Exscientia PLC (NASDAQ:EXAI)
5M ago
EXAI
Exscientia Bolsters Leadership for AI-Driven Drug Design
PremiumCompany AnnouncementsExscientia Bolsters Leadership for AI-Driven Drug Design
5M ago
6K
EXAI
Exscientia Shareholders Greenlight AGM Proposals
Premium
Company Announcements
Exscientia Shareholders Greenlight AGM Proposals
6M ago
6K
EXAI
Exscientia Advances AI-Driven Drug Pipeline, Cuts Costs
Premium
Company Announcements
Exscientia Advances AI-Driven Drug Pipeline, Cuts Costs
6M ago
6K
EXAI

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >